Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Μορφή: Βιβλίο
Γλώσσα:English
Έκδοση: Geneva : World Health Organization, 2001.
Θέματα:

MARC

LEADER 00000nam a2200000 u 4500
001 1190
003 GR-PADA
005 20230803141859.0
008 130912s2001 en af||e b eng d
020 |a 9173920637 
040 |a GrATPDL  |d ΕΘΝΙΚΗ ΣΧΟΛΗ ΔΗΜΟΣΙΑΣ ΥΓΕΙΑΣ-ΚΕΝΤΡΙΚΗ ΒΙΒΛΙΟΘΗΚΗ  |c ΠΑΝΕΠΙΣΤΗΜΙΟΥΠΟΛΗ ΑΘΗΝΩΝ 
041 0 |a eng 
082 |a 362.1969792 
245 0 0 |a Guidelines for using HIV testing technologies in surveillance :  |b selection, evaluation and implementation. 
260 |a Geneva :  |b World Health Organization,  |c 2001. 
300 |a 38 σ. :  |b εικ., πίν. ;  |c 30 εκ. 
504 |a Βιβλιογραφία: σ. 37-38. 
650 0 |a Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας.  |9 879 
650 0 |a Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV)  |9 3882 
650 0 |a AIDS (Disease)  |9 880 
650 0 |a HIV.  |9 3883 
942 |2 ddc  |c BK  |h 362.1969792 GUI  |6 362_196979200000000_GUI 
952 |0 0  |1 0  |2 ddc  |4 0  |6 362_196979200000000_GUI  |7 1  |9 2001  |a MAIN  |b MAIN  |d 2020-01-10  |l 0  |o 362.1969792 GUI  |p 00001429  |r 2020-01-10  |t 1  |w 2020-01-10  |y BK 
999 |c 1659  |d 1659 

Εγγραφή στο Ευρετήριο Αναζήτησης

_version_ 1784614217442131968
building Campus Library III
collection LIB3 Catalog
dewey-full 362.1969792
dewey-hundreds 300 - Social sciences
dewey-ones 362 - Social problems and services to groups
dewey-raw 362.1969792
dewey-search 362.1969792
dewey-sort 3362.1969792
dewey-tens 360 - Social problems and services; associations
format Book
fullrecord {"leader":"01183nam a2200253 u 4500","fields":[{"001":"1190"},{"003":"GR-PADA"},{"005":"20230803141859.0"},{"008":"130912s2001 en af||e b eng d"},{"020":{"subfields":[{"a":"9173920637"}],"ind1":" ","ind2":" "}},{"040":{"subfields":[{"a":"GrATPDL"},{"d":"\u0395\u0398\u039d\u0399\u039a\u0397 \u03a3\u03a7\u039f\u039b\u0397 \u0394\u0397\u039c\u039f\u03a3\u0399\u0391\u03a3 \u03a5\u0393\u0395\u0399\u0391\u03a3-\u039a\u0395\u039d\u03a4\u03a1\u0399\u039a\u0397 \u0392\u0399\u0392\u039b\u0399\u039f\u0398\u0397\u039a\u0397"},{"c":"\u03a0\u0391\u039d\u0395\u03a0\u0399\u03a3\u03a4\u0397\u039c\u0399\u039f\u03a5\u03a0\u039f\u039b\u0397 \u0391\u0398\u0397\u039d\u03a9\u039d"}],"ind1":" ","ind2":" "}},{"041":{"subfields":[{"a":"eng"}],"ind1":"0","ind2":" "}},{"082":{"subfields":[{"a":"362.1969792"}],"ind1":" ","ind2":" "}},{"245":{"subfields":[{"a":"Guidelines for using HIV testing technologies in surveillance :"},{"b":"selection, evaluation and implementation."}],"ind1":"0","ind2":"0"}},{"260":{"subfields":[{"a":"Geneva :"},{"b":"World Health Organization,"},{"c":"2001."}],"ind1":" ","ind2":" "}},{"300":{"subfields":[{"a":"38 \u03c3. :"},{"b":"\u03b5\u03b9\u03ba., \u03c0\u03af\u03bd. ;"},{"c":"30 \u03b5\u03ba."}],"ind1":" ","ind2":" "}},{"504":{"subfields":[{"a":"\u0392\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03af\u03b1: \u03c3. 37-38."}],"ind1":" ","ind2":" "}},{"650":{"subfields":[{"a":"\u03a3\u03cd\u03bd\u03b4\u03c1\u03bf\u03bc\u03bf \u03b5\u03c0\u03af\u03ba\u03c4\u03b7\u03c4\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03b9\u03ba\u03ae\u03c2 \u03b1\u03bd\u03b5\u03c0\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2."},{"9":"879"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"\u0399\u03cc\u03c2 \u03c4\u03b7\u03c2 \u03b1\u03bd\u03b8\u03c1\u03ce\u03c0\u03b9\u03bd\u03b7\u03c2 \u03b1\u03bd\u03bf\u03c3\u03bf\u03b1\u03bd\u03b5\u03c0\u03ac\u03c1\u03ba\u03b5\u03b9\u03b1\u03c2 (HIV)"},{"9":"3882"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"AIDS (Disease)"},{"9":"880"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"HIV."},{"9":"3883"}],"ind1":" ","ind2":"0"}},{"942":{"subfields":[{"2":"ddc"},{"c":"BK"},{"h":"362.1969792 GUI"},{"6":"362_196979200000000_GUI"}],"ind1":" ","ind2":" "}},{"952":{"subfields":[{"0":"0"},{"1":"0"},{"2":"ddc"},{"4":"0"},{"6":"362_196979200000000_GUI"},{"7":"1"},{"9":"2001"},{"a":"MAIN"},{"b":"MAIN"},{"d":"2020-01-10"},{"l":"0"},{"o":"362.1969792 GUI"},{"p":"00001429"},{"r":"2020-01-10"},{"t":"1"},{"w":"2020-01-10"},{"y":"BK"}],"ind1":" ","ind2":" "}},{"999":{"subfields":[{"c":"1659"},{"d":"1659"}],"ind1":" ","ind2":" "}}]}
id lib3_1659
illustrated Illustrated
institution University of West Attica
isbn 9173920637
language English
physical 38 σ. : εικ., πίν. ; 30 εκ.
publishDate 2001
publisher World Health Organization,
record_format marc
spelling Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
Geneva : World Health Organization, 2001.
38 σ. : εικ., πίν. ; 30 εκ.
Βιβλιογραφία: σ. 37-38.
Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879
Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882
AIDS (Disease) 880
HIV. 3883
spellingShingle Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879
Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882
AIDS (Disease) 880
HIV. 3883
title Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
title_auth Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
title_full Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
title_fullStr Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
title_full_unstemmed Guidelines for using HIV testing technologies in surveillance : selection, evaluation and implementation.
title_short Guidelines for using HIV testing technologies in surveillance :
title_sort guidelines for using hiv testing technologies in surveillance selection evaluation and implementation
title_sub selection, evaluation and implementation.
topic Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας. 879
Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV) 3882
AIDS (Disease) 880
HIV. 3883
topic_facet Σύνδρομο επίκτητης ανοσολογικής ανεπάρκειας.
Ιός της ανθρώπινης ανοσοανεπάρκειας (HIV)
AIDS (Disease)
HIV.